GeneReach Biotechnology Corp. (TPEX:4171)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
17.35
-0.20 (-1.14%)
Aug 26, 2026, 1:30 PM CST

GeneReach Biotechnology Financials Overview

Millions TWD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
238.08232.74206.49225.46750.021,012
Revenue Growth
6.10%12.71%-8.42%-69.94%-25.89%18.09%
Gross Profit
173.3160.93118.2827.58490.07746.98
Operating Income
-53.38-79.86-131.22-229.29241.34482.35
Net Income
-43.09-110.28-118.73-166.27221.34376.62
Earnings Per Share
-0.75-1.93-2.07-2.893.776.45
EPS Growth
-----41.59%44.19%

Revenue by Geography

Fiscal YearFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '24 Dec '23 Dec '22 Dec '21
Vietnam
32.6719.6914.7217.910.15
Taiwan
30.3227.2932.4441.93468.59
Indonesia
23.1624.928.6763.76243.78
The Philippines
22.1810.0311.9113.7810.44
India
23.3715.7613.0621.821.88
Other Countries
75.343.4928.5933.1818.53
Thailand
-15.241823.0731.97
Saudi Arabia
13.5818.718.089.8854.17
Panama
12.1720.3920.0115.112.11
Mainland China
-10.9819.3522.6960.08
Total
232.74206.49225.46750.021,012

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
395.82289.76413.98502.72748.61663.43
Total Debt
213.34219.1267.23248.74389.95369.78
Net Cash (Debt)
182.4870.67146.75253.98358.66293.65
Net Cash Growth
--51.84%-42.22%-29.19%22.14%133.48%
Net Cash Per Share
3.191.242.554.426.055.01

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
13.63-13.52-23.22-38.67357.63348.99
Capital Expenditures
-12.37-6.36-7.12-23.53-49.87-19.56
Free Cash Flow
1.26-19.87-30.35-62.21307.76329.43
Free Cash Flow Growth
-----6.58%206.11%

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
72.79%69.14%57.28%12.23%65.34%73.81%
Operating Margin
-22.42%-34.31%-63.55%-101.70%32.18%47.66%
Pretax Margin
-20.93%-50.04%-56.65%-96.84%36.32%46.38%
Profit Margin
-18.10%-47.38%-57.50%-73.75%29.51%37.21%
FCF Margin
0.53%-8.54%-14.70%-27.59%41.03%32.55%

Dividends

Fiscal YearFY 2022FY 2021
Period EndingDec '22 Dec '21
Dividend Per Share
1.2003.636
Dividend Per Share Growth
-67.00%45.43%
Dividend Yield
2.34%6.03%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
----13.7110.07
Forward PE
-5.875.875.875.875.87
P/FCF Ratio
786.56---9.8611.52
PS Ratio
4.184.667.9710.054.053.75